HK1258960A1 - 2環性雜環化合物 - Google Patents
2環性雜環化合物Info
- Publication number
- HK1258960A1 HK1258960A1 HK19101442.1A HK19101442A HK1258960A1 HK 1258960 A1 HK1258960 A1 HK 1258960A1 HK 19101442 A HK19101442 A HK 19101442A HK 1258960 A1 HK1258960 A1 HK 1258960A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- biheterocyclic
- compound
- biheterocyclic compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyrane Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2016006205 | 2016-01-15 | ||
| JP2016173510 | 2016-09-06 | ||
| PCT/JP2017/000819 WO2017122722A1 (ja) | 2016-01-15 | 2017-01-12 | ２環性複素環化合物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1258960A1 true HK1258960A1 (zh) | 2019-11-22 |
Family
ID=59311258
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK19101442.1A HK1258960A1 (zh) | 2016-01-15 | 2019-01-28 | 2環性雜環化合物 |
Country Status (7)
| Country | Link |
|---|---|
| US (4) | US10323024B2 (zh) |
| EP (1) | EP3404023A4 (zh) |
| JP (2) | JP6742343B2 (zh) |
| CN (1) | CN108779090B (zh) |
| HK (1) | HK1258960A1 (zh) |
| TW (1) | TWI744275B (zh) |
| WO (1) | WO2017122722A1 (zh) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108779090B (zh) * | 2016-01-15 | 2022-07-26 | 住友制药株式会社 | 2环性杂环化合物 |
| CN111621279A (zh) * | 2020-06-05 | 2020-09-04 | 赛科思能源技术(重庆)有限责任公司 | 一种油田开发中后期提高采收率的渗吸驱油剂 |
| WO2023072945A1 (en) | 2021-10-25 | 2023-05-04 | Syngenta Crop Protection Ag | Pesticidally active heterocyclic derivatives with sulfur containing substituents |
| WO2024089023A1 (en) | 2022-10-25 | 2024-05-02 | Syngenta Crop Protection Ag | Pesticidally active heterocyclic derivatives with sulfur containing substituents |
| WO2024094575A1 (en) | 2022-10-31 | 2024-05-10 | Syngenta Crop Protection Ag | Pesticidally active heterocyclic derivatives with sulfur containing substituents |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2001276694A1 (en) | 2000-07-28 | 2002-02-13 | Sumitomo Pharmaceuticals Company, Limited | Nerve regeneration promoters containing semaphorin inhibitor as the active ingredient |
| WO2003062440A1 (fr) | 2002-01-21 | 2003-07-31 | Sumitomo Pharmaceuticals Co., Ltd. | Derive de xanthone |
| EP1475382B1 (en) * | 2002-01-24 | 2008-12-10 | Dainippon Sumitomo Pharma Co., Ltd. | Compounds as semaphorin inhibitors |
| AUPS255402A0 (en) | 2002-05-27 | 2002-06-13 | Monash University | Agents and methods for the treatment of disorders associated with oxidative stress |
| JO2478B1 (en) | 2003-06-19 | 2009-01-20 | جانسين فارماسوتيكا ان. في. | (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists |
| JP4820170B2 (ja) | 2003-12-05 | 2011-11-24 | 大日本住友製薬株式会社 | 虚血性神経障害治療又は予防剤 |
| JP4953297B2 (ja) * | 2004-09-15 | 2012-06-13 | 塩野義製薬株式会社 | Ｈｉｖインテグラーゼ阻害活性を有するカルバモイルピリドン誘導体 |
| JP2006335683A (ja) * | 2005-06-02 | 2006-12-14 | Dainippon Sumitomo Pharma Co Ltd | キサントン化合物 |
| MY144974A (en) | 2005-06-14 | 2011-11-30 | Eisai R&D Man Co Ltd | 1,2-di(cyclic) substituted benzene derivatives |
| JP2008013530A (ja) * | 2006-07-10 | 2008-01-24 | Dainippon Sumitomo Pharma Co Ltd | キサントン化合物の製造方法 |
| WO2012018069A1 (ja) | 2010-08-06 | 2012-02-09 | 大日本住友製薬株式会社 | 脊髄損傷治療用製剤 |
| JP5898619B2 (ja) | 2010-08-06 | 2016-04-06 | 大日本住友製薬株式会社 | 水溶性薬物放出制御製剤 |
| ES2577009T3 (es) * | 2011-02-25 | 2016-07-12 | Keio University | Agente terapéutico para daño del nervio sensorial corneal que contiene un inhibidor de semaforina como principio activo |
| WO2015021226A1 (en) | 2013-08-07 | 2015-02-12 | Board Of Regents, The University Of Texas System | Analogs of vinaxanthone and xanthofulvin, methods of synthesis, and methods of treatments thereof |
| JP2015113324A (ja) | 2013-12-13 | 2015-06-22 | 大日本住友製薬株式会社 | クロメノン化合物の製造方法 |
| JP2016037472A (ja) * | 2014-08-08 | 2016-03-22 | 大日本住友製薬株式会社 | 新規セマフォリン３ａ阻害剤 |
| CN108779090B (zh) | 2016-01-15 | 2022-07-26 | 住友制药株式会社 | 2环性杂环化合物 |
-
2017
- 2017-01-12 CN CN201780016957.7A patent/CN108779090B/zh active Active
- 2017-01-12 TW TW106100963A patent/TWI744275B/zh active
- 2017-01-12 US US16/070,014 patent/US10323024B2/en active Active
- 2017-01-12 WO PCT/JP2017/000819 patent/WO2017122722A1/ja active Application Filing
- 2017-01-12 JP JP2017561156A patent/JP6742343B2/ja active Active
- 2017-01-12 EP EP17738476.5A patent/EP3404023A4/en active Pending
-
2019
- 2019-01-28 HK HK19101442.1A patent/HK1258960A1/zh unknown
- 2019-04-24 US US16/392,732 patent/US10870642B2/en active Active
-
2020
- 2020-07-28 JP JP2020127470A patent/JP7019000B2/ja active Active
- 2020-10-26 US US17/079,761 patent/US11440905B2/en active Active
-
2022
- 2022-07-22 US US17/870,955 patent/US11731960B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP7019000B2 (ja) | 2022-02-14 |
| TWI744275B (zh) | 2021-11-01 |
| US20190016711A1 (en) | 2019-01-17 |
| US10870642B2 (en) | 2020-12-22 |
| JPWO2017122722A1 (ja) | 2018-11-01 |
| EP3404023A4 (en) | 2019-11-13 |
| EP3404023A1 (en) | 2018-11-21 |
| JP2020183436A (ja) | 2020-11-12 |
| US10323024B2 (en) | 2019-06-18 |
| US11731960B2 (en) | 2023-08-22 |
| WO2017122722A1 (ja) | 2017-07-20 |
| CN108779090B (zh) | 2022-07-26 |
| TW201726665A (zh) | 2017-08-01 |
| US11440905B2 (en) | 2022-09-13 |
| JP6742343B2 (ja) | 2020-08-19 |
| US20210198242A1 (en) | 2021-07-01 |
| US20220380353A1 (en) | 2022-12-01 |
| US20190308958A1 (en) | 2019-10-10 |
| CN108779090A (zh) | 2018-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB201602934D0 (en) | Compounds | |
| GB201604027D0 (en) | Compounds | |
| GB201604020D0 (en) | Compounds | |
| GB201610854D0 (en) | Compounds | |
| GB201619694D0 (en) | Compounds | |
| GB201620119D0 (en) | Compounds | |
| HK1258960A1 (zh) | 2環性雜環化合物 | |
| GB201608777D0 (en) | Compounds | |
| PL3464336T3 (pl) | Związki | |
| HK1255832A1 (zh) | 吡喃並二吡啶化合物 | |
| GB201604022D0 (en) | Compounds | |
| GB201521524D0 (en) | Compound | |
| GB201604030D0 (en) | Compounds | |
| GB201613946D0 (en) | Compounds | |
| GB201617103D0 (en) | Compound | |
| GB201621520D0 (en) | Compounds | |
| GB201604029D0 (en) | Compounds | |
| GB201610497D0 (en) | Compound | |
| GB201604031D0 (en) | Compounds | |
| GB201518950D0 (en) | Compound | |
| HK1251574A1 (zh) | 四氫噁庚英吡啶化合物 | |
| GB201619526D0 (en) | Compound | |
| GB201619531D0 (en) | Compound | |
| GB201622072D0 (en) | Compounds | |
| GB201621762D0 (en) | Herbicial Compounds |